ABISA’s Post

📚Completed another educational activity offered by the American Academy of Allergy, Asthma, and Immunology on the management of patients with Asthma and Chronic Spontaneous Urticaria(CSU). Gained valuable insights into the latest treatment approaches. I would like to express my gratitude to the AAAAI for the informative session. #AAAAI #AsthmaManagement #UrticariaManagement #CME

Answer this poll in the Whova app in preparation for our panel covering Management of Challenges During Immunotherapy American Academy of Otolaryngic Allergy (AAOA) Annual Meeting starts in 2 days

During the last American College of Allergy, Asthma and Immunology (ACAAI) Tonya Winders, CEO and President of Global Allergy & Airways Patient Platform made a presentation of the "Urticaria voices Study" highlighting how chronic spontaneous urticaria remains uncontrolled with antihistamine treatment. 84% of patients using H1 antihistamines had inadequate control and had to up-dose them an average of 2.9 times. Tonya stated: “Yet even with this use of antihistamines, we know that greater than 60% of patients still have uncontrolled disease". The Urticaria Voices study really aimed to assess the perceptions of patients living with CSU globally but also physician treatment patterns. Read more at: https://ow.ly/vWfn50QcjU4

What causes #NasalPolyps and what does that mean for treatment? Learn about the role of biologics in managing nasal polyps by watching our free #PatientEducationProgram with the Asthma and Allergy Foundation of America ➡️ https://bit.ly/49EOLF5 🏷️ #NasalPolypsTreatment #AAFA #NasalPolypsManagement #PatientEdu